References
- SalehMNRaischKPStackhouseMAGrizzleWEBonnerJAMayoMSCombined modality therapy of A431 human epidermoid cancer using anti-EGFR antibody C225 and radiationCancer Biother Radiopharm19991445146310850332
- RapidisADVermorkenJBBourhisJTargeted therapies in head and neck cancer: past, present and futureRev Recent Clin Trials2008315616618782074
- BorocksteinBLacoutureMAgulnikMThe role of inhibitors of epidermal growth factor in management of head and neck cancerJ Natl Compr Canc Netw20087696706
- LangerCJTargeted therapy in head and neck cancer: state of the art 2007 and review of clinical applicationsCancer2008122635264518442098
- RobertFEzekielMPSpencerSAPhase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerJ Clin Oncol2001193234324311432891
- BonnerJAHarrariPGiraltJAzarniaNShinDMCohenRBRadiotherapy plus cetuximab for squamous cell carcinoma of the head and neckN Eng J Med2006354567578
- BonnerJAHarariPMGiraltJCohenBJonesCHSurRJRadiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalLancet Oncol201011212819897418
- BonnerJHarariPMGiraltJThe relationship of cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximabInt J Radiat Oncol Biol Phys200563S73
- LenzJHCutsemEVKhambata-FordSMulticenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refratory to irinotecan, oxaliplatin, and fluoropyrimidinesJ Clin Oncol2006244914492117050875
- LiBYuanMKimIAChangCMBernhardEJShuHKMutant epidermal growth factor receptor displays increased signalling through the phospahtdylinosotol – 3 kibnase/AKT pathway and promotes radioresistance in cells of astrocytic originOncogene2004234594460215077177
- BudachWBölkeEHorneyBSevere cutaneous reaction during radiation therapy with concurrent cetuximabN Eng J Med2007357514515
- HerbstRSArquetteMShinDMDickeKVokesEEAzarniaNPhase II multicenter study of the epidermal growth factor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckJ Clin Oncol2005235568557716009950
- BurtnessBGoldwasserMFloodWMattarBForastiereAAEastern Cooperative Oncology GroupPhase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group StudyJ Clin Oncol2005238646865416314626
- BernierJCetuximab in the treatment of head and neck cancerExpert Rev Anticancer Ther2006111539155217134359